Mary Hill
Psychiatric/Mental Health · Houston, TXNPI 1982087581
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 233 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,712 and has fallen 88.4% since, to $198 in 2025. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 233 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$577
- Johnson & Johnson$575
- Otsuka America Pharmaceutical, Inc.$435
- Supernus Pharmaceuticals, Inc.$434
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$343
- Alkermes, Inc.$318
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,838100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 17 | $577 |
| Johnson & Johnson | 26 | $575 |
| Otsuka America Pharmaceutical, Inc. | 19 | $435 |
| Supernus Pharmaceuticals, Inc. | 34 | $434 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $343 |
| Alkermes, Inc. | 14 | $318 |
| Corium, LLC | 17 | $294 |
| Ironshore Pharmaceuticals Inc. | 12 | $225 |
| AbbVie | 12 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $188 |
| Teva Pharmaceuticals USA, Inc. | 9 | $167 |
| Lundbeck LLC | 9 | $157 |
| Convatec Inc. | 1 | $154 |
| Vanda Pharmaceuticals Inc. | 8 | $131 |
| E.r. Squibb & Sons, L.L.C. | 1 | $129 |
| Sunovion Pharmaceuticals Inc. | 12 | $123 |
| Tris Pharma Inc | 4 | $77 |
| Axsome Therapeutics, Inc. | 4 | $73 |
| Neos Therapeutics, LP | 4 | $60 |
| Indivior Inc. | 2 | $47 |
| OWP Pharmaceuticals, Inc. | 2 | $45 |
| Idorsia Pharmaceuticals US Inc | 3 | $41 |
| Eisai Inc. | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,846 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 11 | $81 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Houston
- Natalie TellezHouston$602K
- Britney PridgenHouston$57K
- Linzi LeightonHouston$16K
- Samantha SharpeHouston$14K
- Jennifer RobinsonHouston$12K
- Tracy HicksLongview$684K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.